[18], who linked early hormonal attenuation post-SG to suboptimal weight maintenance, and by Nosso et al
Inrecent times Cabaletta has started to map an FDA-facing path toward smaller registrational-style cohorts while it continues to expand clinical experience
Disodium [2-[(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] Phosphate 33
Future multi-region MRS studies examining GSH simultaneously in the thalamus, occipital cortex, and other brain regions within the same patients would help clarify whether GSH reduction is specific to the thalamus or represents a more widespread phenomenon